NCT00380939
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site San Diego, California, United States